期刊文献+

鼻咽癌中国1992、2008分期和国际抗癌联盟2010分期标准的比较研究 被引量:13

The comparative analysis of nasopharyngeal carcinoma among Chinese 1992, 2008 and union for international cancer control (UICC) 2010 staging systems
原文传递
导出
摘要 目的比较鼻咽癌中国1992、2008分期和国际抗癌联盟(UICC)2010分期标准之间的一致性,评价它们在预测鼻咽癌放疗疗效中的价值。方法回顾分析2000-2005年间347例无远处转移的初治鼻咽癌患者临床资料,对每例患者分别用中国1992、2008和UICC2010分期标准进行T、N和临床分期。采用Kappa法分析3种分期标准问各期病例数分布的一致性。采用Kaplan—Meier法分别计算3种分期标准的5年总生存率、局部无复发和无远处转移生存率,并用Logrank检验其差异。结果中国2008分期和UICC2010分期标准之间的临床分期、T和N分期的病例构成比例的一敛性均优于它们各自与1992分期之间的比较,Kappa值分别为0.700、0.881和0.722。3种分期标准下各临床分期的总生存曲线比较只发现Ⅲ与Ⅳ期间的不同,其中2008分期和UICC2010分期标准下Ⅲ与Ⅳ期间的不同(χ^2=4.48,P=0.034和χ^2=8.88,P=0.003),而1992分期则相似(χ^2=0.40,P=0.526)。3种分期标准的局部无复发生存率各T1与T2和T2与T3及T3与T4期间的比较均相似(χ^2=1.85、0.55、0.50,P=0.174、0.467、0.479和χ^2=1.25、2.10、1.99,P=0.264、0.148、0.159及χ^2=0.77、0.60、0.87,P=0.381、0.441、0.350)。在3种分期标准的各期无远处转移生存率中,1992分期标准的N0与N1、N1与N2、N2与N3间均相似(χ^2=3.71、3.11、2.01,P=0.054、0.078、0.156),2008分期标准的N1与N2、N2与N3间不同(χ^2=10.49、5.06,P=0.001、0.024);UICC2010分期标准中仅N1与N2间不同(χ^2=7.73,P=0.005)。结论中国2008分期和UICC2010分期标准对鼻咽癌放疗疗效的预测价值相近,且均优于1992分期。 Objective To compare the agreement among Chinese 1992, 2008 and UICC 2010 staging systems of nasopharyngeal carcinoma ( NPC ) and evaluate their predictive value of radiotherapeutie prognosis. Methods 347 NPC patients without distant metastasis treated in our hospital from 2000 to 2005 were retrospectively analyzed. Every patient was categorized into T, N, and clinical stage by Chinese 1992, 2008 and UICC 2010 staging systems, respectively. Kappa value was used to evaluate the agreement among three systems. Kaplan-Meier method was used to analyze the 5-year overall survival (OS), local-free survival (LFS) and distant metastasis-free survival (DMFS), the difference between subgroup was tested by Logrank. Results The agreement of clinical stage, T and N stage between Chinese 2008 and UICC 2010 staging system was better than that of them compared to 1992 staging system, Kappa value were 0. 700 0. 881 and 0. 722. The agreement of T stage was better than N and clinical stage among these three staging system. The difference of OS between stage Ⅲand stage Ⅳ was significant in Chinese 2008 and UICC 2010 staging system ( χ^2 = 4. 48,P = 0. 034 ; χ^2 = 8.88,P = 0. 003 ), and with no different in 1992 staging system ( χ^2 =0. 40,P =0. 526). There was no significant difference of LFS between T1 and T2 ,T2 and T3 ,T3 and T4 in all staging systems ( χ^2 = 1.85,0. 53,0. 50,P = 0. 174,0. 467,0. 479 ; χ^2 = 1.25,2. 10,1.99, P = 0. 264, 0. 148,0. 159 ; χ^2 = 0. 77 , 0. 60,0. 87 , P = 0.3 81 , 0.441 , 0.3 5 0 ) . There were no significant differences of TDMFS between N0, N1, N2 and N3 in 1992 staging system, while there was significant differences of DMFS between N1 and N2, N2 and N3 in 2008 stage system, N1 and N2 in UICC 2010 stage system. Conclusions The predictive value of Chinese 2008 and UICC 2010 staging system for prognosis were similar, and were better than that of 1992 staging system in NPC.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2011年第4期270-275,共6页 Chinese Journal of Radiation Oncology
关键词 鼻咽肿瘤/放射疗法 预后 分期系统 Nasopharyngeal neoplasm/radiotherapy Prognosis Stage system
  • 相关文献

参考文献10

  • 1刘泰福,徐国镇.全国鼻咽癌会议纪要[J].中华放射肿瘤学杂志,1992,0(4):5-10. 被引量:132
  • 2Sobin LH, Gospodarowicz MK, Wittekind CH. International union against cancer ( UICC ). TNM Classification of malignant tumours. 7th ed. New York : Wiley-Blackwel1,2009. 被引量:1
  • 3沈春英,胡超苏,朱国培,何少琴.178例鼻咽癌患者不同临床分期方法与预后的比较[J].中国癌症杂志,2006,16(4):267-271. 被引量:6
  • 4Liu MZ, Tang LL, Zong JF, et al. Evaluation of sixth edition of AJCC staging system for nasopharyngeal carcinoma and proposedimprovement. Int J Radiat Oncol Biol Phys,2008,72 : 1115-1123. 被引量:1
  • 5Mao YP, Xie FY, Liu LZ, et al. Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging. Int J Radiat Oncol Biol Phys ,2009,73 : 1326-1334. 被引量:1
  • 6Lee AW, Au JSK, Teo PML, et al. Staging of nasopharyngeal carcinoma: suggestions for improving the current UICC/AJCC staging system. Clin 0ncol,2004,16 : 269 -276. 被引量:1
  • 7Ng WT, Chan SH, Lee AW, et al. Parapharyngeal extension of nasopharyngeal carcinoma: still a significant factor in era of modem radiotherapy? Int J Radiat Oncol Biol Phys,2008,72:1082-1089. 被引量:1
  • 8Mao YP, Liang SB, Liu LZ, et al. The N staging system innasopharyngeal carcinoma with radiation therapy oncology group guidelines for lymph node levels based on magnetic resonance imaging. Clin Cancer Res,2008,14:7497-7503. 被引量:1
  • 9Tang LL, Li L, Mao YP, et al. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma detected by magnetic resonance imaging: prognostic value and staging categories. Cancer, 2008,113 : 347 -354. 被引量:1
  • 10Ma J, Liu LZ, Tang LL, et al. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: prognostic value and staging categories. Clin Cancer Res,2007,13 : 1445-1452. 被引量:1

二级参考文献19

  • 1Chien CR,Chen SW,Hsieh C,et al.Retrospective comparison of the AJCC 5th edition Classification for nasopharyngeal carcinoma with the AJCC 4th edition:an experience in Taiwan[J].Jpn J Clin Oncol,2001,31(8):363-369. 被引量:1
  • 2Au JS,Law CK,Foo W,et al.In-depth evaluation of the AJCC/UICC 1997 staging system of nasopharyngeal carcinoma:prognostic homogeneity and proposed refinements[J].Int J Radiat Oncol Biol Phys,2003,56(2):413-426. 被引量:1
  • 3Casanova M,Ferrari A,Gandola L,et al.Undifferentiated nasopharyngeal carcinoma in children and adolescents:comparison between staging systems[J].Ann Oncol,2001,12(8):1157-1162. 被引量:1
  • 4Teo P,Leung SF,Yu P,et al.A retrospective comparison between different stage classification for nasopharyngeal carcinoma[J].Br J Radiol,1991,64(766):901-908. 被引量:1
  • 5Lee AW,Foo W,Poon YF,et al.Staging of nasopharyngeal carcinoma:evaluation of N-staging by Ho and UICC / AJCC system[J].Clin Oncol,1996,8(3):146-154. 被引量:1
  • 6Chua DT,Sham JS,Choy D,et al.Preliminary report of the Asian-oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma[J].Cancer,1998,83(11):2270-2283. 被引量:1
  • 7Al-Sarraf M,LeBlanc M,Giri PG,et al.Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer.Phase Ⅲ randomized Intergroup study 0099[J].J Clin Oncol,1998,16(4):1310-1317. 被引量:1
  • 8Chan AT,Teo PM,Leung TW,et al.A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma[J].Int J Radiat Oncol Biol Phys,1995,33(3):569-577. 被引量:1
  • 9International Nasopharynx Cancer Study Group.Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin,epirubicin,bleomycin) plus radiotherapy versus radiotherapy alone in stage Ⅳ (N≥2,M0) undifferentiated nasopharyngeal carcinoma:a positive effect on progression-free survival[J].Int J Radiat Oncol Biol Phys,1996,35(3):463-469. 被引量:1
  • 10Altun M,Fandi A,Dupuis O,et al.Undifferentiated nasopharyngeal cancer(UCNT):current diagnostic and therapeutic aspects[J].Int J Radiat Oncol Biol Phys,1995,32(3):859-877. 被引量:1

共引文献136

同被引文献108

引证文献13

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部